相关实验视频

Updated: May 7, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

血蛋白质组学的综合孟德尔随机化和局部化分析,以确定膀癌的新治疗点

Jieming Zuo¹, Junhao Chen¹, Zhiyong Tan¹

¹Yunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.

Journal of Cancer

|July 31, 2025

概括

这项研究确定了与膀癌风险相关的新型血蛋白,为早期诊断和新的向治疗提供了潜力. 研究人员发现,NOV和GSTM3等特定蛋白质可能是理解和治疗这种侵袭性癌症的关键.

科学领域:

在瘤学瘤学.
蛋白质组学是指蛋白质组学.
遗传学遗传学是一个

背景情况:

膀癌呈现高复发率和化学抵抗性,需要改进诊断和治疗方法.
目前的治疗方法有效性有限,这突显了对新生物标志物和有针对性的干预措施的需求.

研究的目的:

为了确定与膀癌风险因果相关的血蛋白点.
探索已识别的蛋白质在膀癌生物学和治疗策略中的潜在作用.

主要方法:

血蛋白质组数据 (UKB-PPP,deCODE) 与全基因组关联研究 (GWAS) 数据的整合.
应用两个样本的门德尔随机化 (MR),贝叶斯定位和SMR/HEIDI分析.
分子对接,以评估候选蛋白质的药物结合潜力.

主要成果:

确定了199种与膀癌风险显著相关的血蛋白.
五个核心候选蛋白质 (SLURP1,LY6D,WFDC1,NOV,GSTM3) 被突出显示.
NOV和GSTM3显示了与膀癌的强有力的因果关系,以及与激素调节药物潜在的结合.

结论:

已识别的血蛋白与膀癌有因果关系,涉及免疫逃避,抗氧化剂防御和新陈代谢中的作用.
这些发现为膀癌生物学提供了新的见解.
准确治疗和药物重新定位的潜在目标被揭示出来.

关键词:

膀癌是一种癌症.循环中的蛋白质.毒品目标. 毒品目标.蛋白质组学蛋白质组学

更多相关视频

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...